AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Colt CZ Group SE

Investor Presentation Mar 27, 2025

1046_rns_2025-03-27_93c63b91-3166-4821-8fb5-6f7c494044d7.pdf

Investor Presentation

Open in Viewer

Opens in native device viewer

COLT CZ GROUP SE PRELIMINARY FINANCIAL RESULTS 2024

INVESTOR PRESENTATION

LEGAL DISCLAIMER

IMPORTANT – YOU MUST READ THE FOLLOWING BEFORE CONTINUING

  • This presentation (the "Presentation") has been prepared by Colt CZ Group SE, with its registered office at náměstí Republiky 2090/3a, Nové Město, 110 00 Praha 1, Identification Number 291 51 961, registered in the Commercial Register maintained by the Municipal Court in Prague, Section H, Insert 962 (the "Colt CZ"). By attending the meeting where this Presentation is made or by reading the Presentation document, you agree to be bound by the following terms and conditions.
  • The Presentation has been prepared with due care. However, certain inconsistencies or omissions might have appeared herein. Therefore, it is recommended that any person intending to undertake any investment decision on any security issued by Colt CZ or any member of its group (the "Group") shall only rely on information released as an official communication by Colt CZ in accordance with the legal and regulatory provisions that are binding for Colt CZ.
  • Past performance can not be taken as an indication or guarantee of future results, and no representation or warranty, express or implied, is made regarding future performance. Colt CZ does not (i) warrant that the assumptions underlying the forward-looking statements in this Presentation are free from errors, (ii) accept any responsibility for the future accuracy of the opinions expressed in this Presentation, or (iii) undertake any obligation to update the statements in this Presentation to reflect subsequent events. The forward-looking statements in this Presentation are made only as of the date hereof. Neither delivery of this Presentation nor any further discussions between Colt CZ and you shall, under any circumstances, result in any implication that there has been no change in Colt CZ affairs since such date.
  • Forward-looking statements, including statements relating to expectations regarding future financial results, give no guarantee or assurance that such results will be achieved. Expectations of the Colt CZ management are based on present knowledge, awareness and/or views of the management members and are dependent on many factors, which may cause the actual results that Colt CZ will achieve may differ materially from those discussed in this Presentation. Many such factors are beyond the present knowledge, awareness and/or control of Colt CZ, or cannot be predicted. None of the Group, Colt CZ or its directors, managers, advisers or representatives of such persons makes any representation or warranty, expressed or implied, as to (i) the fairness, accuracy, completeness or correctness of this Presentation, (ii) the sufficiency of this Presentation for your purposes. or (iii) the appropriateness of this Presentation for any purpose other than that for which it was intended. Nothing contained herein is or should be relied upon as a promise or representation, whether as to the past or the future.
  • This Presentation should not be construed as legal, regulatory, tax, accounting, investment or other advice. Nothing contained herein shall constitute any representation or warranty as to the future performance of any security, credit, currency, rate or other market or economic measure. No reliance may be placed for any purpose whatsoever on this Presentation.
  • This Presentation was prepared for information purposes only and is neither a purchase nor sale offer nor a solicitation of a n offer to purchase or sell any securities or financial instruments or an invitation to participate in any commercial venture. This Presentation is neither an offer nor an invitation to purchase or subscribe for any securities in any jurisdiction, and no statements contained herein may serve as a basis for any agreement, commitment or investment decision, or may be relied upon in connection with any agreement, commitment or investment decision.

AGENDA AND TODAY'S PRESENTERS

AGENDA PRESENTERS

JAN DRAHOTA Chairman of the Board of Directors Colt CZ Group SE

RADEK MUSIL Vicechairman of the Board of Directors CEO of Colt CZ Group SE

JAN ZAJÍC Member of the Board of Directors CEO of Česká zbrojovka a.s.

JANA MATOUŠKOVÁ

Head of Group Finance Colt CZ Group SE

2024 PRELIMINARY UNAUDITED RESULTS

REVENUES

CZK 22,376 m

↑ 50.6% vs 2023

CZK 4,599 m ↑ 50.9% vs 2023

ADJUSTED EBITDA

ADJUSTED NET PROFIT

CZK 1,933 m

↓ 5.7% vs 2023

ADJUSTED EPS CZK 41 ↓ 29.8% vs 2023

PRELIMINARY RESULTS 2024 – COMMENTS

Record organic growth of revenues (+17.6%), accompanied with a flat adj. EBITDA profitability.

The acquisition of S&B had a significant positive effect on both revenue growth and adjusted EBITDA, supported by the company's strong operating profitability.

Double-digit revenue growth achieved on the US commercial market (+26.8%), below-expected profitability performance of the US business due to relatively unfavorable product mix, unsuccessful entry of Colt to the bolt action rifle market (bad market timing resulting in inventory write off) and insufficient cost control. Profitability in North America further impacted by new projects/investments for future (Mk 47 etc.).

Net profit down due to higher interest costs. Post ABB net leverage down to 2.26x.

REVENUES – SIGNIFICANT SHIFT DUE TO S&B CONSOLIDATION

In % of total revenues In % of total revenues

FY 2023 FY 2024

REVENUE BREAKDOWN BY GEOGRAPHY REVENUE BREAKDOWN BY GEOGRAPHY – SEGMENTS

REVENUES AND EBITDA MARGIN - OWN PRODUCTION VS TRADING

FY 2024 CUSTOMER SEGMENTS SPLIT 50:50

MLE share grew from 10% to 50% since IPO

FY 2024 RECORD YEAR IN GROUP'S HISTORY

In '000 units In CZK m

BREAKDOWN BY FIREARMS UNITS SOLD QUARTERLY REVENUES & ADJ . EBITDA SEASONALITY

FY 2024 NET PROFIT AFFECTED BY FINANCIAL RESULT AND ONE-OFFS

ADJUSTED VS. REPORTED NET PROFIT

ADJUSTED EARNINGS PER SHARE 1

COMMENTS

Full breakdown of adjustments available on page 21

CAPEX IN LINE WITH 2024 GUIDANCE

CAPITAL EXPENDITURES 1

  • COMMENTS
  • FY 2024 CAPEX in line with FY CAPEX guidance (i.e. up to 5% of revenues)
  • Major investments in 2024 in production lines in both segments, mainly in capacity increase, innovation, modernization and automatization of manufacturing processes
  • FY 2025 CAPEX guidance in line with medium-term strategy

Notes: Financial results are unaudited

1 – Corresponds to the paid acquisition of non-current assets

2 – Guidance is based on the management expectations as of the date of presentation

3 – CZK 148 m of CAPEX not included in 2024 figures as payment was postponed to 2025

NET LEVERAGE DOWN POST ABB TRANSACTION

EXPECTED DEBT MATURITY PROFILE

(INC. ACQUISITION FINANCING) NET FINANCIAL DEBT 1 & NET LEVERAGE RATIO 2

COMMENTS

  • Net leverage significantly below 3x as communicated by the Company, creating room for potential M&A
  • In December company repaid part for the S&B acquisition loan in the amount of EUR 94 m
  • Cash generative business of both businesses will allow leverage reduction going forward, with expected acquisition loan repayment by 2029
  • Preference of bonds to loans

Notes: 1 – Net financial debt is defined as long-term and short-term bonds, bank loans and borrowings and finance lease liabilities (non-current and current), less cash and cash equivalents, less other current financial assets (marketable securities) 2 – Net leverage ratio is defined as the ratio of net financial debt at the end of the period to LTM adjusted EBITDA, formula based on the loan legal documentation

ACQUISITION OF SELLIER & BELLOT – D&A IMPACT

COMMENTS

  • Increase in Amortization due to Purchase Price Allocation of S&B acquisition significantly affecting Net profit/EPS
  • Significant impact on net profit and EPS in the next 3 years, approximately CZK 600 m impact on the net profit per year

PRIORITIES AND GUIDANCE 2025

REVENUES

CZK 25 bn ↑ 12% yoy plus/minus 7%

EBITDA

CZK 5.5 bn ↑ 20% yoy plus/minus 7%

Net interest costs CZK 631 mio

Indicative split per quarters

CZK
b
n
Q
1
Q
2
Q
3
Q
4
FY 2025
Revenues 5.2 6.3 6 7.5 25
Adj.
EBITDA
1.0 1.5 1.3 1.7 5.5

Notes: Guidance is based on the management expectations as of the date of presentation

PRIORITIES AND GUIDANCE 2025

The Board of Directors will propose a cash dividend of CZK 847 million (CZK 15 per share) for 2024, representing 44% of the adjusted net profit. Separately, the Board also plans to allocate CZK 847 million for a share buyback program. This buyback is intended to enhance long-term shareholder value by supporting EPS growth and potentially increasing the stock's free float.

We see significant, "once in a generation" business opportunities in the M&LE segment globally, NATO and EU countries remain priority, but selected Asian countries could have significant importance as well. Key will be to finalise/win and to execute on time.

We intend to continue support of Ukraine via 2 key projects – CZ BREN 2 ToT, S&B ammunition technology provision.

The US commercial market to develop in line with the overall economy and consumer behavior, no political impulses expected due to the very firm pro gun stance of the current administration and Congress. Introduction of new products is the key for success. Strong pipeline aligned for both CZ and Colt.

Disciplined approach to costs overall, but a special emphasis on the North America business, focus on the right insourcing and realization of operational efficiencies.

Are there segments which will become significant due to the changing landscape and where Colt CZ Group should be present? (larger/new calibers - both ammo and firearms, UAV etc.?).

RISKS AND OPPORTUNITIES FOR GUIDANCE

RISKS

  • Further deterioration of the US commercial market, global economic outlook
  • Timing to market of key products in the pipeline
  • Several significant M&LE projects still to be finalized to be able to start potential deliveries (strongly weighted towards Q3 and Q4 of 2025)
  • FX development (only EBITDA impact as company well hedged)

OPPORTUNITIES

  • Some of the potential contracts would be historically large for the Group if finally signed, and deliveries started in 2025.
  • Impact of trading activities of non-produced products should be more significant in terms of profitability in 2025, but still uncertainty on timing/size.

THANK YOU FOR YOUR ATTENTION

APPENDIX

FY 2024 GUIDANCE VS ACTUALS

ACTUAL

ADJUSTED EBITDA RECONCILIATION

In CZK '000 FY 2024 FY
2023
Operating profit 2,001,018 1,861,966
Depreciation and amortization 1,478,824 801,721
EBITDA 3,479,842 2,663,687
ESOP related costs 418,730 313,455
M&A costs1 14,960 71,237
S&B inventory step up 513,596 -
S&B commodity hedging 56,334 -
Wasted
project

Bolt action rifles
69,624 -
Wasted
project

Foundry
21,642 -
Legacy
costs
24,136 -
Adjusted EBITDA 4,598,864 3,048,379

ADJUSTED NET PROFIT RECONCILIATION

In CZK '000 FY
2024
FY
2023
Earnings before tax 1,379,838 2,509,562
Tax expenses (335,263) (467,024)
Net income 1,044,575 2,042,538
Earn-out revaluation -
ESOP related costs 418,730 313,455
M&A costs1 14,960 71,237
Wasted
project

Bolt action rifles
69,624 -
Wasted
project

Foundry
21,642 -
Legacy
costs
24,136 -
S&B inventory step up 513,596 -
Negative goodwill - (384,482)
Bank fee –
acquisition loan S&B
100,864 -
One-off expenses related to the bond issue 10,289 8,641
Adjusted earnings before tax (Adj. EBT) 2,553,679 2,518,413
Effective tax rate on Adj. EBT (2024 ~24.3%; 2023 ~18.6%) (620,474) (468,671)
Adjusted Net Income 1,933,205 2,049,742

NET INTEREST COSTS GUIDANCE

In CZK '000 000; G 2025
Interest
expenses
898
Hedging
impact
-124
Deposit revenues -143
Net interest
costs
631
Effective interest rate 3.7%

ASSUMPTIONS

Stable FX rate EUR/CZK

  • No extraordinary debt repayment
  • Stable market interest rates

CONSOLIDATED PROFIT AND LOSS STATEMENT

In '000 CZK 31
Dec
2024
31
Dec
2023
Revenues from the sale of own products, goods and services 22,375,792 14,855,581
Other operating income 159,638 89,789
Change in inventories developed internally (629,980) 887,593
Own work capitalized 338,746 172,976
Raw materials and consumables used (11,335,766) (8,065,419)
Services (2,487,683) (1,959,627)
Personnel costs (4,489,688) (3,083,096)
Depreciation and amortization (1,478,824) (801,721)
Other operating expenses (331,521) (210,225)
Allowances (119,696) (23,885)
Operating profit 2,001,018 1,861,966
Interest income 784,854 756,541
Interest expense (1,307,949) (894,604)
Other financial income 113,159 251,596
Other financial expenses (202,902) (72,120)
Gains or losses from derivative transactions (8,872) 221,019
Bargain
purchase
gain
- 384,482
Share in the profit of associates after tax 530 682
Profit before tax 1,379,838 2,509,562
Income tax (335,263) (467,024)
Profit for the period 1,044,575 2,042,538
Items that may be subsequently reclassified to the statement of profit or loss
Cash flow hedges –
remeasurement of effective portion of hedging instruments
(803,310) (468,398)
Foreign currency translation of foreign operations 74,551 183,745
Other comprehensive income (728,759) (284,653)
Comprehensive income for the period 315,816 1,757,885
Profit for the period attributable to:
Owner of the parent company 1,044,575 2,042,538
Comprehensive income for the period attributable to:
Owner of the parent company 315,816 1,757,885
Net earnings per share attributable to the owner of the parent company (CZK per share)
Basic 22 58
Diluted 22 58

CONSOLIDATED BALANCE SHEET 1/2

In CZK '000 31 Dec 2024 31 Dec 2023
ASSETS
Non-current assets
Intangible assets 10,403,416 3,413,881
Goodwill 8,489,707 2,547,480
Property, plant and equipment 9,582,545 4,281,449
Advance payment for financial investment - 2,690,040
Equity-accounted securities and investments 44,102 40,795
Financial derivatives 413,372 1,013,168
Trade and other receivables 20,021 61,891
Other receivables 2,593 2,556
Deferred tax assets 75,589 21,245
Total non-current assets 29,031,345 14,072,505
Current assets
Inventories 7,456,512 5,298,077
Trade and other receivables 2,829,759 1,774,947
Provided loans 20,017 -
Other financial assets 12,531 908,580
Financial derivatives 127,174 149,047
Other receivables 555,882 351,165
Tax receivables 81,210 93,751
Cash and cash equivalents 5,917,768 3,328,684
Total current assets 17,000,853 11,904,251
Total assets 46,032,198 25,976,756

CONSOLIDATED BALANCE SHEET 2/2

In CZK '000 31 Dec 2024 31 Dec 2023
EQUITY AND LIABILITIES
Capital and reserves
Share capital 5,646 3,516
Share premium 13,477,795 1,942,818
Capital funds 1,641,512 1,641,512
Cash flow hedge reserve (203,494) 599,816
Foreign exchange translation reserve (68,137) (142,688)
Accumulated profits 5,175,107 5,229,872
Equity attributable to the owner of the Company 20,028,429 9,274,846
Non-controlling interest - -
Total equity 20,028,429 9,274,846
Non-current liabilities
Bonds, bank loans and borrowings 16,336,227 9,040,540
Financial derivatives 532,473 244,169
Lease liabilities 58,922 62,052
Trade and other payables 46,802 42,022
Other payables 10,387 14,569
Provisions 101,095 76,188
Deferred tax liability 2,561,948 722,783
Employee benefit liabilities 234,725 255,721
Total non-current liabilities 19,8882,579 10,458,044
Current liabilities
Bonds, bank loans and borrowings 1,474,910 2,573,744
Financial derivatives 394,262 11,038
Lease liabilities 22,267 25,619
Other financial liabilities - 44,580
Trade and other payables 1,573,335 1,746,796
Other payables 2,333,203 1,655,094
Provisions 57,870 30,084
Tax liabilities 248,236 142,084
Employee benefit liabilities 17,107 14,827
Total current liabilities 6,121,190 6,243,866
Total liabilities 26,003,769 16,701,910
Total equity and liabilities 46,032,198 25,976,756

CONSOLIDATED CASH FLOW STATEMENT

In '000 CZK 31 Dec 2024 31 Dec 2023
Cash flows from principal economic activity (operating activity)
Profit from ordinary activity before tax 1,379,838 2,509,562
Depreciation/amortization of non-current assets 1,478,824 801,721
Change in allowances and provisions 170,879 22,276
Gain/Loss on sale of fixed assets (1,990) (2,659)
Interest expense and interest income 523,095 138,063
Share in the profit of associates (530) (682)
Unrealized foreign exchange gain and losses (343,250) 14,988
Partial earnout settlement - 406,915
Other financial assets – remeasurement (113,402) (160,692)
Cash flow hedging – remeasurement of the effective portion of hedging instruments (1,001,100) (468,398)
Bargain purchase gain - (384,482)
Share-based payments 411,729 293,068
Adjustments for other non-cash transactions 62,197 52,921
Net operation cash flows before changes in working capital 2,566,290 3,222,601
Change in working capital 1,403,132 -926,498
Change in receivables and deferrals 682,840 (162,505)
Change in liabilities and accruals 216,589 244,040
Change in inventories 503,703 (1,008,033)
Cash flow from operating activities 3,969,422 2,296,103
Paid interest (1,327,694) (880,196)
Interest received 826,407 756,881
Income tax paid for ordinary activity (797,443) (759,473)
Net cash flow from operating activities 2,670,692 1,413,315
Cash flows from investing activities
Acquisition of non-current assets (920,565) (924,156)
Proceeds from the sale of non-current assets 1,990 2,964
Acquisition of subsidiaries – opening balance (5,231,350) (723,902)
Acquisition of subsidiaries – cash and cash equivalents 443,521 150,863
Acquisition of equity-accounted securities and investments (3,776) (1,212)
Advance paid for financial investment - (2,690,040)
Employee benefit liabilities (54,240) (27,014)
Acquisition of other financial assets (12,531) -
Proceeds from sale of other financial assets 1,021,982 -
Provided loans (18,889) 7,700
Net cash flow from investing activities (4,773,858) (4,204,797)
Cash flows from financing activities
Proceeds from bonds 588,000 1,917,756
Proceeds from share 2,242,673 -
Dividends paid to owners (260,445) (864,393)
Proceeds from loans 7,382,973 2,295,087
Loan repayment (5,324,774) (22,333)
Leases repayment (25,650) (32,762)
Net cash flow from financing activities 4,602,777 3,293,353
Net change in cash and cash equivalents 2,499,611 501,871
Opening balance of cash and cash equivalents 3,328,684 2,825,781
Effect of exchange rate on cash and cash equivalents 89,473 1,032
Closing balance of cash and cash equivalents 5,917,768 3,328,684

COLT CZ GROUP STRUCTURE AS OF 31/12/2024

Holding companies No asset companies

Notes: Group structure as of 31/12/2024

THANK YOU

Colt CZ Group SE

náměstí Republiky 2090/3a 110 00 Prague 1, Czech Republic www.coltczgroup.com [email protected]

Talk to a Data Expert

Have a question? We'll get back to you promptly.